20 June 2013
Keywords: gsk, darapladib, prevents, necrotic, core, expansion, uk
Article | 08 September 2008
UK drug major GlaxoSmithKline says that results of the IBIS-2 study showed that use of the selective lipoprotein-associated phospholipase A2
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 September 2008
19 June 2013
© 2013 thepharmaletter.com